FDA Approved: CLOZAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for CLOZAPINE submitted by Teva Pharmaceuticals USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia
• Treatment-resistant Schizophrenia

Drugs mentioned

• Clozapine (Clozapine)

Snippet

SUPPL AP for CLOZAPINE (CLOZAPINE)